Netherlands· NL-3b119595012d
Ceplene 0,5 mg/0,5 ml, oplossing voor injectie
A histamine dihydrochloride product containing histaminedihydrochloride, registered in Netherlands by Laboratoires Delbert. The same ATC class is registered in 10 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Histamine dihydrochloride is registered in 10 of 19 countries.
Countries holding a registration under ATC L03AX14 (histamine dihydrochloride), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 6 of them publish a price we can compare per daily dose
Histamine dihydrochloride · ATC L03AX14
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- HISTAMINEDIHYDROCHLORIDE
- Manufacturer
- Laboratoires Delbert
- Country
- Netherlands (NL)
- ATC code
- L03AX14
- ATC class
- Histamine dihydrochloride
- Defined daily dose
- 0.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/08/477
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
42 interactions on record for histamine dihydrochloride.
Graded by severity as the source publishes them — 42 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Histamine dihydrochloride · interactions on record
42 records
- 42 moderate
Most severe, free to view
- DiphenhydraminA04AB05moderate
- CyproheptadinA15AA01moderate
- DiphenhydraminN01BX06moderate
- HydroxyzineN05BB01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Histamine dihydrochloride in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IrelandCeplene 0.5 mg/0.5 ml solution for injectionLaboratoires DELBERT
- United States2nd CHANCE MOBILITY Pain ReliefALPHA NUTRITION, LLC
- United KingdomCeplene 0.5mg/0.5ml solution for injection vialsMeda Pharmaceuticals Ltd
- BelgiumCeplene 0.5 mg/0.5 mlNoventia Pharma
- GermanyAlk-Prick Positiv-KontrolleAlk-Abelló Arzneimittel Gmbh
- SwitzerlandPrick-Test Positivkontrolle, PricktestlösungDermapharm AG
- CanadaHISTATROLALK-ABELLO INC
- FranceALYOSTAL PRICK CONTROLE POSITIF 10 mg/ml, solution pour prick-test cutanéSTALLERGENES
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Alk Prick Positiv Kontrolle, Alyostal Prick, Allergenextrakte
- Belgium · Histamine Di Hcl Hal Allergy, Soluprick Contrôle Positif
- Bulgaria · Алиостал Прик, Алергенен Екстракт От Дървесни Полени, Алиостал Прик, Алергенен Екстракт От Животински Произход
- Czechia · Alyostal Prick, Soluprick Sq
- Germany · Alk-Prick Positiv-Kontrolle, Histamin-Kontrollösung Bencard Allergie
- Denmark · Alk Soluprick Positiv Kontrol
- Finland · Soluprick Positiivinen Kontrolli, Soluprick® Positiv Kontroll
- France · Alyostal Prick Controle Positif, Soluprick Controle Positif
- United Kingdom (Northern Ireland) · Soluprick Positive Control
- Ireland · Soluprick Positive Control
- Iceland · Ceplene, Soluprick Positiv Kontrol
- Liechtenstein · Ceplene
- Lithuania · Alyostal Prick Teigiama Kontrolė
- Luxembourg · Soluprick Contrôle Positif, Soluprick Positiv Kontrolle
- Norway · Ceplene, Soluprick Positiv Kontroll
- Poland · Alyostal, Kontrola Dodatnia Prick Test Hal Allergy
- Portugal · Histamina Hal Allergy
- Sweden · Soluprick Positiv Kontroll
- Slovenia · Alyostal Vbodni
- Slovakia · Alyostal Prick, Soluprick
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/545ca410-ac9b-48aa-a8f9-9394342541ba GET /v1/drugs/545ca410-ac9b-48aa-a8f9-9394342541ba?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor injectie",
"route": "Subcutaan gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/ceplene-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Histamine Dihydrochloride",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp73584",
"excipients": [
"NATRIUMCHLORIDE",
"NATRIUMHYDROXIDE (E 524)",
"WATER VOOR INJECTIE",
"ZOUTZUUR (E 507)"
],
"substances": [
"HISTAMINEDIHYDROCHLORIDE"
],
"leaflet_url": null,
"authorised_at": "2008/10/07",
"procedure_number": "EMEA/H/C/000796",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/08/477",
"additional_monitoring": "Y"
}See everything about histamine dihydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.